Senolytic drug may offer back pain relief by targeting aging cells

A Canadian-led study has found that senolytic drugs o-vanillin and RG-7112 could treat chronic low back pain by clearing aging, inflammation-causing cells. The therapy showed promising results in preclinical models, reducing pain and improving tissue health. Experts now urge clinical trials and exploration of Ayurvedic senolytic options for chronic pain.